Related by context. All words. (Click for frequent words.) 67 Bronchiectasis 67 aerosolized AAT 66 relapsing remitting MS RRMS 66 arthritis PsA 66 Chronic lymphocytic leukemia 66 systemic juvenile idiopathic 65 Lupus Nephritis 65 Granted Orphan Drug 65 Kepivance 65 alpha1 antitrypsin deficiency 65 exocrine pancreatic insufficiency EPI 65 Meets Primary Endpoint 64 acetonide FA 64 BCG refractory carcinoma 64 refractory chronic lymphocytic 64 chronic granulomatous disease 64 oropharyngeal candidiasis OPC 64 Receives Orphan Drug Designation 64 LymphoStat B belimumab 64 Investigational Treatment 64 Orphan Status 64 beta 1a 64 Atypical Hemolytic Uremic Syndrome 63 Lupus nephritis 63 HeFH 63 Vitrasert R 63 A1PI 63 chronic ITP patients 63 Aviptadil 63 leukemia AML 63 Granulocyte Colony Stimulating Factor 63 relapsed leukemia 63 terlipressin 63 severe malignant osteopetrosis 63 Lambert Eaton Myasthenic 63 Files IND 63 INTEGRILIN R 63 rheumatoid arthritis RA psoriatic 63 Peginterferon alfa 2b 63 Systemic lupus erythematosus SLE 63 Myelodysplastic Syndrome MDS 63 GW# [003] 63 superficial basal cell carcinoma 63 Initiates Phase II 63 Iluvien ® 63 acyclovir Lauriad R 62 Diabetic Macular Edema 62 kidney urologic 62 R bendamustine hydrochloride 62 Dupuytren Contracture 62 Neulasta R 62 PEGylated anti 62 Myelofibrosis 62 Diabetic Neuropathy 62 Naive Patients 62 Wafer polifeprosan 62 CYT# potent vascular disrupting 62 1 Proteinase Inhibitor 62 Polyneuropathy 62 Daclizumab 62 smoldering multiple myeloma 62 Stargardt Macular Dystrophy SMD 62 relapsing multiple sclerosis 62 vinorelbine tartrate 62 TNF Tumor Necrosis Factor 62 Chronic lymphocytic leukemia CLL 62 Acute Myeloid Leukaemia AML 62 adult chronic ITP 62 atypical Hemolytic Uremic Syndrome 62 Silodosin 62 INSPIRE Trial Phase III 62 Soft Tissue Sarcoma 62 interferon alpha IFN alpha 62 homozygous familial hypercholesterolemia 62 chronic rheumatic 62 Ribavirin causes 62 Pirfenidone 62 debilitating autoimmune 62 Inhalation Aerosol 61 Syndrome LEMS 61 tumors GIST 61 Liprotamase 61 AAT Deficiency 61 Rivastigmine 61 metastatic gastric 61 IBS C 61 Neovascular Age Related Macular 61 Advanced Melanoma 61 Prolongs Survival 61 Tofacitinib 61 Chronic Fatigue Syndrome CFS 61 Lymphocytic 61 MELAS 61 Safinamide 61 AAT deficiency 61 HQK 61 Noxafil 61 induced macular edema 61 neovascular age 61 Fingolimod 61 progressive neurodegenerative disorder 61 primary immunodeficiency PI 61 SJIA 61 dasatinib Sprycel 61 Idiopathic Pulmonary Fibrosis 61 acute porphyria 61 Acute myeloid leukemia 61 MAGE A3 ASCI 61 PEGylated Fab fragment 61 Chronic hepatitis B 61 pathologic myopia 61 basiliximab 61 post herpetic neuralgia PHN 61 secondary hyperparathyroidism SHPT 61 vapreotide acetate 61 unresectable stage 61 systemic fungal infections 61 hyperphenylalaninemia HPA due 61 myelodysplastic myeloproliferative diseases 61 RhuDex R 61 Etanercept 61 Cimzia TM 61 opioid induced constipation OIC 61 Irinotecan 61 metastatic malignant 61 Sevelamer 61 Evoltra ® 61 non metastatic resectable 61 Dacogen decitabine 61 steroid refractory GvHD 61 Community Acquired Pneumonia 61 Febuxostat 61 Mg Usa 61 neurogenic bladder 61 complement inhibitor eculizumab 61 Plaquenil 61 erlotinib Tarceva ® 61 Tyrosine Kinase Inhibitors 61 Squamous 60 Cutaneous T 60 autoantibody positive 60 Juvenile Idiopathic Arthritis JIA 60 Initiates Enrollment 60 Hormone Refractory Prostate Cancer 60 RANK Ligand inhibitor 60 neuroendocrine cancers 60 receptor tyrosine kinase inhibitor 60 Zorbtive TM 60 1 proteinase inhibitor 60 Acute Renal Failure 60 Chronic HCV 60 drug ISA# 60 psoriatic arthritis PsA 60 predominantly classic subfoveal 60 IMiDs 60 esophageal candidiasis 60 Ganciclovir 60 RezularTM 60 Plecanatide 60 AEG# 60 Mucositis 60 RhuDex ® 60 Successfully Completes Phase 60 Leukemias 60 Janus kinase 60 diarrhea predominant irritable 60 Tibotec Therapeutics division 60 PLX STROKE targeting 60 Sudhir Agrawal D.Phil 60 SNT-MC#/idebenone 60 either acutely decompensated 60 venous stasis ulcers 60 Prodrug 60 Malignant Melanoma 60 Completes Patient Enrollment 60 mitoxantrone plus 60 RTP #i 60 PF # [002] 60 Severe Primary IGFD 60 progressive neurodegenerative 60 ZACTIMA TM ZD# 60 CTAP# Capsules 60 metastatic neuroendocrine tumors 60 ara C 60 delivers fluocinolone acetonide FA 60 Aryplase 60 Maroteaux Lamy syndrome 60 ACTIQ ® 60 Initiate Phase 60 subependymal giant cell 60 mildly symptomatic 60 chronic idiopathic thrombocytopenic purpura 60 Lymphoid 60 tuberous sclerosis TS 60 rheumatoid arthritis psoriatic arthritis 60 MPS VI 60 Campath ® 60 chronic thromboembolic pulmonary 60 Neovascular 60 dasatinib Sprycel ® 60 Mantle Cell Lymphoma 60 Gleevec resistant 60 Severe Sepsis 60 Kit CD# positive 60 immune thrombocytopenic purpura 60 sitagliptin metformin 60 oropharyngeal candidiasis 60 1 Antitrypsin Deficiency 60 Initiates Clinical Trial 60 formerly LymphoStat B 60 inhalation powder 60 Critical Limb Ischemia CLI 60 IMiDs ® 60 PROVIGIL ® 60 ALN HPN 60 hematological malignancy 60 pancreatic insufficiency 60 constipation predominant irritable bowel 60 alefacept 60 Systemic Delivery 60 PD LID 60 5 HT4 60 chronic myocardial ischemia 60 sJIA 60 interstitial cystitis IC 60 Tasimelteon 60 sargramostim 60 Rilonacept 60 sorafenib tablets 60 Orphan Drug Status 60 Gamunex C 60 Bendamustine 60 Diabetic Ulcers 60 Shows Promise Against 60 NAGS deficiency 60 treat chronic sinusitis 60 Maribavir 60 SPRYCEL ® 60 volociximab 60 Soliris eculizumab 60 psoriasis rheumatoid arthritis 60 Nexavar tablets 60 Morquio 60 Tacrolimus 60 Amigal TM 60 Degarelix 60 advanced hepatocellular carcinoma 60 Adjuvant Treatment 59 reduce serum phosphate 59 ankylosing spondylitis AS 59 Chronic myeloid leukemia 59 invasive candidiasis 59 Plaque Psoriasis 59 Nexavar sorafenib 59 mecasermin 59 Chronic Sinusitis 59 Non Alcoholic Steatohepatitis 59 Fabry Disease 59 gastrin analogue TT 59 Achieves Primary Endpoint 59 Neo Bladder Augment 59 DepoDur 59 P. aeruginosa infection 59 Annamycin 59 Idiopathic Pulmonary Fibrosis IPF 59 myasthenia gravis MG 59 decompensated liver disease 59 anterior uveitis 59 Chronic Myelogenous Leukemia CML 59 Trobalt 59 dual endothelin receptor antagonist 59 Brilique 59 Raptiva R 59 PEGINTRON TM 59 AA Amyloidosis 59 GRNOPC1 contains 59 miconazole Lauriad R 59 benign prostatic hypertrophy BPH 59 Apaziquone 59 liver resection surgeries 59 Genentech Rituxan 59 reslizumab 59 Hsp# Inhibitor 59 hypereosinophilic syndrome 59 methylnaltrexone bromide 59 myocardial infarction ventricular fibrillation 59 Aflibercept 59 AVAPRO 59 thalidomide Thalomid 59 neurological manifestations 59 Myelodysplastic Syndrome 59 active ankylosing spondylitis 59 Ceflatonin R 59 Orphan Designation 59 Bazedoxifene 59 Nilotinib 59 intravenous AAT 59 thetreatment 59 Sapacitabine 59 Campath alemtuzumab 59 erythematosus 59 Omacetaxine 59 miconazole Lauriad ® 59 advanced metastatic renal 59 SNT MC# 59 atypical hemolytic uremic syndrome 59 C1 INH deficiency 59 hepatitis B HBV 59 basal cell carcinoma BCC 59 acute intermittent porphyria 59 biliary tract cancer 59 Fast Track Status 59 pediatric acute lymphoblastic 59 infectious diseases autoimmune diseases 59 Tracleer bosentan 59 AA amyloidosis 59 non splenectomized 59 bronchial hyperresponsiveness 59 Friedreich Ataxia FRDA 59 refractory acute promyelocytic 59 PRN FDA Approves 59 peritumoral brain edema 59 PNP inhibitor 59 Temsirolimus 59 successfully commercialize Iluvien 59 Intravitreal 59 essential thrombocythemia ET 59 Initiates Phase III 59 metastatic bladder 59 Bafetinib 59 Retacrit 59 IAP inhibitor 59 Dementia Related Psychosis 59 familial amyloidotic polyneuropathy FAP 59 Ciclesonide 59 painful compression fractures 59 Ceflatonin 59 TEMODAL 59 Ankylosing spondylitis 59 Gleevec imatinib mesylate 59 Epratuzumab 59 ACZ# 59 Initiate Clinical Trial 59 orphan medicinal product 59 acute myeloid 59 Decitabine 59 HDAC Inhibitor 59 alemtuzumab treated 59 chronic immune thrombocytopenic 59 efalizumab 59 Serostim ® 59 Bayer Nexavar 59 Idiopathic pulmonary fibrosis IPF 59 paroxysmal nocturnal hemoglobinuria PNH 59 Ranibizumab 59 Pseudomonas lung 59 HepDirect prodrug 59 Zenpep 59 Phase 2b Clinical Trial 59 IV acetaminophen 59 MKC# MT 59 interferon beta therapy 59 anagrelide 59 Eraxis 59 R lenalidomide 59 ATTR PN 59 Diabetic Retinopathy DR 59 Firazyr 59 RhuDex ™ 59 Alemtuzumab 59 Azacitidine 59 oxypurinol 59 pouchitis 59 Tramiprosate ALZHEMED TM 59 ADPKD 59 candidate Zelrix 59 Aerosolized 59 Temodar ® 59 mTOR mammalian target 59 benign prostatic hypertrophy 59 Icatibant 59 Systemic lupus erythematosus 59 Tasigna nilotinib 59 nosocomial pneumonia 59 Rheumatoid 59 Central Retinal Vein 59 vWD 59 presumed ocular histoplasmosis 58 Ischemic 58 histone deacetylase HDAC inhibitor 58 overactive bladder syndrome 58 Behcet uveitis 58 Factor VIIa 58 FDA APPROVES 58 toenail onychomycosis 58 pemphigus vulgaris 58 recurrent glioblastoma multiforme GBM 58 Oral Fingolimod 58 idiopathic pulmonary fibrosis IPF 58 acute HAE 58 Pulmonary Arterial Hypertension 58 Prochymal TM 58 Cx# [002] 58 Arcalyst 58 Cloretazine 58 Amgen Neulasta R 58 retinal vein occlusion 58 Patients Treated With 58 bronchogenic carcinoma 58 Orally administered 58 Trandolapril 58 multiple myeloma MM 58 Mipomersen 58 Recombinant Human 58 targeted radiotherapeutic 58 Vaprisol 58 DEB# 58 pancreatic enzyme replacement 58 carcinoma mCRC 58 CIMZIA ™ 58 Kamada AAT 58 nasal calcitonin product 58 Copegus ribavirin 58 hereditary deficiency 58 Mylan Receives Approval 58 lumbar spinal stenosis LSS 58 Peripheral artery disease 58 non nucleoside inhibitor 58 Asthma COPD 58 Nexavar ® 58 Allergic Rhinitis 58 LHON 58 Gefitinib 58 nephropathic cystinosis 58 Chronic Prostatitis 58 recurrent glioblastoma 58 Receives Marketing Authorization 58 herpes labialis 58 calcineurin inhibitor 58 Glioblastoma Multiforme 58 antibody MAb 58 DORIBAX 58 baminercept 58 GTC recombinant human 58 Pivotal Phase III 58 GA GCB 58 Orphan Drug designations 58 Pemetrexed 58 orphan designation 58 Biogen Idec Avonex 58 Lubiprostone 58 metastatic colorectal 58 LUCASSIN 58 Actemra tocilizumab 58 Fast Track designations 58 Eisenmenger syndrome 58 Initiates Clinical 58 osteoporotic vertebral fractures 58 posterior uveitis 58 BENLYSTA TM 58 Vidaza ® 58 Mycophenolate Mofetil 58 Dasatinib 58 Crohns disease 58 generation purine nucleoside 58 ADP receptor antagonist 58 Pooled Analysis 58 Presents Preclinical 58 ACV1 58 Drug Eluting Stent System 58 mertansine 58 IGF 1R inhibitor 58 novel VDA molecule 58 Arranon 58 pulmonary alveolar 58 riociguat 58 Vitrasert ® 58 Launches Generic Version 58 muscular dystrophy cystic fibrosis 58 Retinitis Pigmentosa RP 58 situ CIS 58 SSc 58 Increlex R 58 BRAF V#E 58 Begins Dosing 58 metastatic colorectal carcinoma 58 Letairis ambrisentan 58 ® lenalidomide 58 NYHA Class II 58 chronic eosinophilic leukemia 58 mesylate 58 IL# PE#QQR 58 Oral Calcitonin 58 gastrointestinal reflux 58 use transdermal sumatriptan 58 IGFD 58 Yondelis ® 58 prokinetic agent 58 biologic antibody 58 debilitating complication 58 Prospective Randomized 58 sitaxsentan sodium 58 small molecule tyrosine 58 gastrointestinal disorders characterized 58 Tetrabenazine 58 JAK2 Inhibitor 58 Sezary syndrome 58 Treatment Shows Promise 58 Glatiramer acetate 58 refractory acute myeloid 58 Alkeran 58 cutaneous T 58 Lenalidomide 58 commercialize deforolimus 58 MKC# MKC# PP 58 macrolide antibiotic 58 canakinumab 58 Vandetanib 58 Raptiva ® 58 Biogen Genentech 58 malignant pleural effusion 58 Roche Actemra 58 Pfizer Camptosar 58 Epirubicin 58 Anaplastic 58 Chronic Lymphocytic Leukemia CLL 58 corticosteroid dexamethasone 58 diabetic kidney 58 symptomatic BPH 58 Hemophilia B 58 FDA Orphan Drug 58 Submits Response 58 Systemic Lupus Erythematosus SLE 58 pancreatic enzyme supplements 58 Wet AMD 58 unresectable hepatocellular carcinoma HCC 58 Albugon 58 Receives Orphan Drug 58 Submits IND 58 Avonex interferon beta 1a 58 autosomal recessive disease 58 Aurora Kinase 58 Pazopanib 58 Diabetic neuropathy 58 PsA 58 accumulate preferentially 58 anti inflammatory NSAID 58 cardiotoxic 58 deletion 5q 58 Systemic Lupus Erythematosus 58 chronic opioid 58 relapsed MM 58 eosinophilic asthma 58 inhaled AAT 58 Single Dose 58 Remicade infliximab 58 Alphanate R 58 Velcade bortezomib 58 alfa 2a 58 osteoporotic vertebral compression fractures 58 briakinumab 58 aerosolized KL4 surfactant 58 pulmonary arterial hypertension PAH 58 patients receiving myelosuppressive 58 R Saizen R 58 de novo kidney transplant 58 Hepatocellular Carcinoma 58 metastatic malignant melanoma 58 autoimmune uveitis 58 aplastic anemia AA 58 PKC# 58 tyrosine kinase inhibitor TKI 58 Increlex TM 58 Cancidas 58 investigational oral inhibitor 58 refractory metastatic colorectal cancer 58 Octreolin 58 BioSante Pharmaceuticals Announces 58 Campto 57 Myelodysplastic Syndromes MDS 57 herpetic keratitis 57 metaglidasen 57 Humira adalimumab 57 recessive dystrophic epidermolysis bullosa 57 neurogenic orthostatic hypotension 57 inflammatory acne 57 non alcoholic steatohepatitis 57 Gaucher Disease 57 Vidaza azacitidine 57 bosentan Tracleer 57 Aliskiren 57 Eculizumab 57 Platinol ® 57 chronic HBV infection 57 Personalized Immunotherapy 57 unresectable liver cancer 57 gastric adenocarcinoma 57 CLL SLL 57 multiple sclerosis lupus 57 Pfizer Sutent 57 Intravenous immunoglobulin 57 Relapsing remitting MS 57 rilonacept 57 HoFH 57 Saxagliptin 57 idiopathic PAH 57 Hereditary angioedema HAE 57 diabetic macular edema 57 Critical Limb Ischemia 57 aortic valve stenosis 57 granted Orphan Designation 57 alpha1 antitrypsin AAT deficiency 57 Cryopyrin Associated Periodic Syndromes 57 Afinitor everolimus 57 fentanyl buccal tablet 57 injectable formulation 57 small molecule Hedgehog 57 cystic fibrosis chronic pancreatitis 57 hepatorenal syndrome 57 Moxifloxacin 57 Pivotal Trial 57 Archexin 57 Systemic Sclerosis 57 Kuvan R 57 dacarbazine DTIC 57 precursor acute lymphoblastic 57 juvenile idiopathic arthritis JIA 57 NAVISTAR R 57 Parnate 57 Idiopathic pulmonary fibrosis 57 Factor Xa inhibitors 57 ocular inflammatory 57 liposomal formulation 57 hormone LHRH antagonist 57 biologic DMARD 57 severe gastroparesis 57 Randomized Study 57 IND Application 57 Ozarelix 57 Denufosol 57 Gleevec imatinib 57 Hepsera adefovir dipivoxil 57 rufinamide 57 Ambrisentan 57 Myozyme alglucosidase alfa 57 Tocilizumab 57 P#X# antagonist 57 rasagiline tablets 57 constipation OIC 57 Aortic stenosis 57 Camptosar ® 57 phase III isavuconazole 57 Azmacort R 57 Recombinant interferon alpha 57 uremic pruritus 57 sodium glucose cotransporter 57 Orphan Medicinal Product 57 Tezampanel 57 Endologix Powerlink System 57 Peginterferon Alfa 2a 57 diabetic neuropathic pain 57 smoldering myeloma 57 refractory cutaneous T 57 immunodeficiency disorders 57 Prodarsan R 57 colorectal carcinoma 57 Pegloticase 57 Nipent R 57 Lenocta TM 57 lymphocytic leukemia 57 Carbidopa 57 metastatic renal 57 pan HDAC inhibitor 57 Peripheral artery 57 Preotact R 57 R vitespen 57 Hereditary angioedema 57 pediatric Crohn disease 57 pancreatic NET 57 Contrast Agent 57 treat hyperphosphatemia 57 metastatic GIST 57 IMiDs ® compound 57 5 lipoxygenase inhibitor 57 transthyretin amyloidosis 57 mycosis fungoides 57 Stargardt Macular Dystrophy 57 stage IIIb IV 57 Pafuramidine 57 lucinactant 57 Familial Adenomatous Polyposis FAP 57 buccal tablets 57 nucleotide analogue 57 Refractory Hodgkin Lymphoma 57 Somatuline R Depot 57 CYP#A# CYP#D# 57 leukemia CLL 57 Bayer HealthCare Onyx Pharmaceuticals 57 Pulmonary hypertension 57 arthritis RA 57 Esbriet ® 57 adriamycin 57 Shows Statistically Significant 57 refractory prostate cancer 57 neovascular wet age 57 Hepatocellular Carcinoma HCC 57 Amrubicin 57 Rituxan rituximab 57 CTEPH 57 Ceflatonin ® 57 R abatacept 57 Bucindolol 57 BENLYSTA ® 57 gastrointestinal stromal tumors GIST 57 cell lymphoma CTCL 57 B Cell Lymphoma 57 humanized interleukin 6 57 chronic myeloid 57 uricase 57 receptor blocker 57 IV Busulfex 57 proteasome inhibitor 57 exocrine pancreatic insufficiency 57 Aclidinium 57 GRN# 57 malignant ascites 57 Chronic HCV infection 57 grade cervical dysplasia 57 Chronic Myeloid Leukemia 57 allogeneic bone marrow 57 STELARA TM 57 Gleevec Glivec 57 selective agonist 57 Pathway Inhibitor 57 cirrhosis liver failure 57 targeting miR 57 Parathyroid Hormone 57 virus HCV 57 Candida infections 57 nonsmall cell lung cancer 57 denileukin diftitox 57 paroxysmal nocturnal hemoglobinuria 57 Randomized Phase 57 MTP inhibitor 57 p# MAP kinase inhibitor 57 F#del mutation 57 Moli# 57 Prolastin C 57 Interferon gamma 57 leukemia aplastic anemia 57 Submits NDA 57 Xelox 57 Argatroban 57 choroidal vasculopathy 57 unresectable tumors 57 recurrent NSCLC 57 brivanib 57 Xyfid TM 57 Completes Enrollment 57 squamous cell carcinoma SCC 57 Darusentan 57 nucleoside analog 57 humanized therapeutic 57 etanercept Enbrel 57 sitaxsentan 57 Enlarged prostate 57 UPLYSO 57 Tumor Necrosis Factor 57 Arimoclomol 57 virus HCV protease inhibitor 57 pediatric malignancies 57 Azilect ® 57 schizophrenia CIAS 57 Ixempra 57 interleukin IL -# 57 OvaRex ® MAb 57 Certolizumab pegol 57 endoluminal stent graft 57 salmeterol fluticasone propionate 57 Investigational Oral 57 Orphan designation 57 amrubicin 57 Orphan Drug status 57 RAPTIVA 57 Acute Myelogenous Leukemia AML 57 oral prodrug 57 Pulmonary Arterial Hypertension PAH 57 Cellegesic 57 Non inferiority 57 Commences Phase 57 Melphalan 57 recurrent metastatic 57 Myelodysplastic Syndromes 57 tafamidis 57 Bosentan 57 Initiates Dosing 57 Papillary 57 Huntingtons disease 57 autosomal recessive disorder 57 YONDELIS 57 Initiates Clinical Trials 57 intranasal formulation 57 acute promyelocytic leukemia 57 Angiotensin Converting Enzyme 57 Warfarin Coumadin 57 SinuNase TM 57 Arzerra ofatumumab 57 candidemia 57 Phase 2a Trial 57 oral Hycamtin 57 skeletal metastases 57 GI GVHD 57 PEG interferon 57 plasmid encoding 57 Efficacy Trial 57 Panzem R 57 Major depressive disorder 57 gefitinib Iressa 57 prostanoid 57 investigational therapies 57 blood clotting disorder 57 peritoneal carcinomatosis 57 Evoltra 57 LRAT 57 Spiegelmer ® 57 imatinib Gleevec ® 57 EVIZON TM 57 levocetirizine 57 hepatitis C HCV 57 candesartan cilexetil 57 Uvidem 57 Irritable Bowel Syndrome IBS 57 Xanafide 57 Epidermal Growth Factor Receptor 57 elevated triglyceride levels 57 NR2B selective 57 common hematologic malignancy 57 fusion enhancers 57 Patients Receiving 57 R rilonacept Injection 57 Certican 57 Laquinimod 57 TAXOTERE ® 57 Duchenne Becker 57 Nonalcoholic fatty liver 57 Trabectedin 57 glycopeptide 57 Niemann Pick type 57 Myeloid 57 nonischemic 57 polyneuropathy HIV DSP 57 RhuDex TM 57 inflammatory PDE 57 Chronic myeloid leukemia CML 57 Hervé Hoppenot President 57 docetaxel Taxotere ® 57 Cytomegalovirus CMV 57 gastrointestinal stromal tumor GIST 57 gastrointestinal stromal tumor 56 Grants Orphan Drug 56 Leber Hereditary Optic Neuropathy 56 rheumatoid arthritis osteoarthritis ankylosing 56 Cysteamine 56 Philadelphia Chromosome Positive 56 recurrent glioblastoma multiforme 56 bladder ovarian 56 Novel Oral 56 Chronic Lymphocytic Leukemia 56 multikinase inhibitor 56 Natalizumab 56 Primary Hypercholesterolemia 56 transthyretin TTR 56 candidates Azedra TM 56 oral vancomycin 56 interferon gamma 1b 56 memantine HCl 56 Torisel 56 chronic HBV 56 Antitumor 56 Adenoviral 56 XYOTAX TM 56 tinidazole 56 non CF bronchiectasis 56 Fludara ® 56 tumor xenograft models 56 dyskeratosis congenita 56 refractory anaplastic astrocytoma 56 AERIUS 56 BARACLUDE ® 56 MGd 56 Glioma 56 Keppra ® XR 56 psoriasis Crohn disease 56 Fluconazole 56 pathophysiological effects 56 lomitapide 56 Hexvix ® 56 actinic keratosis 56 Talabostat 56 C1 Inhibitor 56 immuno inflammatory diseases 56 hormone refractory metastatic prostate 56 rALLy 56 specific lectin receptors 56 Dyloject TM 56 Pamidronate 56 gastrointestinal stromal tumors GISTs 56 CYT# QbG# 56 oral FTY# 56 Pseudomonas infections 56 Gets FDA Clearance 56 Entereg TM 56 transplantation HCT 56 syndrome IBS 56 histologic subtype 56 Presents Positive 56 chorea associated 56 Synvisc ONE 56 cell acute lymphoblastic 56 Major Depressive Disorder MDD 56 modafinil Tablets C 56 lupus erythematosus 56 Antiviral Therapy 56 Zirgan 56 lupus scleroderma 56 Troxatyl 56 dirucotide MBP# 56 azacytidine 56 eritoran 56 alpha1 proteinase inhibitor 56 Severe VOD 56 carcinoid syndrome 56 Ulcerative colitis 56 monoclonal anti 56 Sjogren Syndrome 56 Sebivo 56 Onalta TM 56 octreotide acetate 56 Interferon alfa 56 recurrent colorectal cancer 56 Alvesco R 56 ALN PCS 56 severe oral mucositis 56 Relapsed Refractory 56 leukemias lymphomas 56 CIMZIA TM 56 haematologic malignancies 56 Cytotoxic 56 Gastrointestinal GI 56 Basal Cell 56 Glioblastoma multiforme GBM 56 Postherpetic neuralgia PHN 56 liver scarring 56 fluoropyrimidine 56 Elagolix 56 Cannabinor 56 Secondary Hyperparathyroidism 56 Nimotuzumab 56 Bezielle 56 hypophosphatasia 56 lumiliximab 56 headache abdominal pain 56 Diabetic nephropathy 56 Juvenile Idiopathic Arthritis 56 cIAI 56 AMEVIVE 56 virus HCV infection 56 Ophena TM 56 Sanvar R 56 Begin Clinical Trials 56 Immunotherapeutic 56 Iron Overload 56 dihydrochloride 56 Torisel temsirolimus 56 Entocort 56 carcinoid tumors 56 Commence Phase 56 occlusion PAO 56 Progressive Multifocal Leukoencephalopathy 56 Tigecycline 56 lysosomal storage diseases 56 lexidronam injection 56 haematological cancers 56 RoACTEMRA 56 relapsed multiple myeloma 56 pegylated interferons 56 hematologic disorders 56 abacavir Ziagen 56 QVAR 56 Insegia 56 Romiplostim 56 regorafenib 56 FDA Accepts 56 TYGACIL 56 Pivotal Phase 56 Vicinium TM 56 echinocandin 56 Triapine 56 neuromuscular spasm